Maksim Vasilev, Rajasekar Reddy Annapureddy, Chengfeng Ye, Sridhar Regati, Praveen Kumar Gajula, Jonathan Bietsch, Zhirui Wang, Jack D. Brown, Gopal Sirasani, Aravind S. Gangu, Paul Guo, Bo Qu, Chris H. Senanayake
{"title":"Telescoped Two-Step Continuous-Flow Synthesis of Nevirapine Enabled by the On-Demand Generation of NaHMDS","authors":"Maksim Vasilev, Rajasekar Reddy Annapureddy, Chengfeng Ye, Sridhar Regati, Praveen Kumar Gajula, Jonathan Bietsch, Zhirui Wang, Jack D. Brown, Gopal Sirasani, Aravind S. Gangu, Paul Guo, Bo Qu, Chris H. Senanayake","doi":"10.1021/acs.oprd.6c00277","DOIUrl":null,"url":null,"abstract":"<p>A telescoped two-step fully continuous-flow process for\r\nthe synthesis\r\nof nevirapine (trade name: Viramune), a key therapeutic agent for\r\nthe prevention and treatment of HIV-1 infection, has been developed.\r\nThe process employs, for the first time, sodium bis(trimethylsilyl)amide\r\n(NaHMDS) as a homogeneous, process-friendly base for both reaction\r\nstages and enables direct conversion of methyl 2-(cyclopropylamino)nicotinate\r\nand 2-chloro-3-amino-4-picoline to nevirapine without isolation of\r\nthe cyclization intermediate. The optimized process operates with\r\na total residence time of 10 min and delivers crude nevirapine in\r\n91.9% overall isolated yield across two reaction steps, with a space-time\r\nyield of ∼365 g/h/L and 99.6 A% HPLC purity. Furthermore, we\r\ndeveloped an on-demand continuous generation of NaHMDS in diglyme\r\n(up to ∼2.0 M) using a sodium packed-bed column reactor. Using\r\non-demand generated NaHMDS, the telescoped synthesis yielded crude\r\nnevirapine in 90.7% isolated yield (∼340 g/h/L space-time yield\r\nand 99.5 A% purity), providing a scalable and cost-effective alternative\r\nto NaH applied in the current commercial synthesis.</p>","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"30 10","pages":"2822–2832"},"PeriodicalIF":3.3000,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Organic Process Research & Development","FirstCategoryId":"92","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.oprd.6c00277","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/1 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 0
Abstract
A telescoped two-step fully continuous-flow process for
the synthesis
of nevirapine (trade name: Viramune), a key therapeutic agent for
the prevention and treatment of HIV-1 infection, has been developed.
The process employs, for the first time, sodium bis(trimethylsilyl)amide
(NaHMDS) as a homogeneous, process-friendly base for both reaction
stages and enables direct conversion of methyl 2-(cyclopropylamino)nicotinate
and 2-chloro-3-amino-4-picoline to nevirapine without isolation of
the cyclization intermediate. The optimized process operates with
a total residence time of 10 min and delivers crude nevirapine in
91.9% overall isolated yield across two reaction steps, with a space-time
yield of ∼365 g/h/L and 99.6 A% HPLC purity. Furthermore, we
developed an on-demand continuous generation of NaHMDS in diglyme
(up to ∼2.0 M) using a sodium packed-bed column reactor. Using
on-demand generated NaHMDS, the telescoped synthesis yielded crude
nevirapine in 90.7% isolated yield (∼340 g/h/L space-time yield
and 99.5 A% purity), providing a scalable and cost-effective alternative
to NaH applied in the current commercial synthesis.
期刊介绍:
The journal Organic Process Research & Development serves as a communication tool between industrial chemists and chemists working in universities and research institutes. As such, it reports original work from the broad field of industrial process chemistry but also presents academic results that are relevant, or potentially relevant, to industrial applications. Process chemistry is the science that enables the safe, environmentally benign and ultimately economical manufacturing of organic compounds that are required in larger amounts to help address the needs of society. Consequently, the Journal encompasses every aspect of organic chemistry, including all aspects of catalysis, synthetic methodology development and synthetic strategy exploration, but also includes aspects from analytical and solid-state chemistry and chemical engineering, such as work-up tools,process safety, or flow-chemistry. The goal of development and optimization of chemical reactions and processes is their transfer to a larger scale; original work describing such studies and the actual implementation on scale is highly relevant to the journal. However, studies on new developments from either industry, research institutes or academia that have not yet been demonstrated on scale, but where an industrial utility can be expected and where the study has addressed important prerequisites for a scale-up and has given confidence into the reliability and practicality of the chemistry, also serve the mission of OPR&D as a communication tool between the different contributors to the field.